Publications

  • HOME
  • Publications
  • 99. Fascaplysin exerts anti-cancer effects through the suppression of survivin and HIF-1α by inhibiting RTK-mediated mTOR-4EBP1 pathways 

    Oh, T.-I; Lee, Y.-M.; Ko, Y.-S; Mah, S.; Kim, J.; Kim, Y.; Reddy, R. H.; Kim, Y. J.; Hong, S.; Lim, J.-H. 

    Int. J. Mol. Sci. 201718, 2074.

  • 98. Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of ALK by Structure-Based Design 

    Mah, S.; Park, J. H.; Jung, H.-Y.; Ahn, K.; Choi, S.; Tae, H. S.; Jung, K. H.; Rho, J. K.; Lee, J. C.; Hong, S-S.; Hong, S. 

    J. Med. Chem. 201760, 9205.

  • 97. Visible Light-Promoted Synthesis of Spiroepoxy Chromanone Derivatives via A Tandem Oxidation/Radical Cyclization/Epoxidation Process 

    Jung, S.; Kim, J.; Hong, S. 

    Adv. Synth. Catal. 2017359, 3945. (Highlighted as a Cover)

  • 96. Direct Phosphonation of Quinolinones and Coumarins Driven by the Photochemical Activity of Substrates and Products 

    Kim, I.; Min, M.; Kang, D.; Kim, K.; Hong, S.

    Org. Lett. 201719, 1394. 

  • 95. Metal- and Oxidant-Free S−P(O) Bond Construction via Direct Coupling of P(O)H with Sulfinic Acids 

    Moon, Y.; Moon, Y.; Choi, H.; Hong, S. 

    Green Chem. 2017, 19, 1005.

  • 94. Efficient Synthesis of Anthraquinones from Diaryl Carboxylic Acids via Pd(II)-Catalyzed and Visible Light-Mediated Transformations 

    Kim, K.; Min, M.; Hong, S. 

    Adv. Synth. Catal. 2017359, 848.

  • 93. Application of Fragment-Based De Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 beta

    Park, S.; Shin, Y.; Kim, J.; Hong, S. 

    J. Med. Chem. 2016, 59, 9018.

  • 92. Pd(II)-Catalyzed Tandem Synthesis of Acenes Using Carboxylic Acids as Traceless Directing Groups 

    Kim, K.; Vasu, D.; Im. H.; Hong, S. 

    Angew. Chem. Int. Ed. 2016, 55, 8652. 

  • 91. Identification of Lead Small Molecule Inhibitors of Glycogen Synthase Kinase-3 beta Using a Fragment-Linking Strategy 

    Kim, J.; Moon, Y.; Hong, S.

    Bioorg. Med. Chem. Lett. 201626, 5669. 

  • 90. HS-173, a Novel PI3K Inhibitor Suppresses EMT and Metastasis in Pancreatic Cancer

    Rumman, M.; Jung, K. H.; Fang, Z.; Yan, H. H.; Son, M. K.; Kim, S. J.,; Kim, J.; Park, J. H.; Hong, S.; Hong, S.-S.

    ONCOTARGET 2016, 47, 78029.